Peripheral neuropathy in scleroderma

Muscle and Nerve

Volumn 28, Issue 3, 2003, Pages 330-335

  Poncelet, Ann N ^a   Connolly, M Kari ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Electrophysiology; Neuropathy; Quantitative sensory testing; Scleroderma; Systemic sclerosis

Indexed keywords

ALDACTAZINE; AMITRIPTYLINE; AMLODIPINE; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DILTIAZEM; GABAPENTIN; LEVOTHYROXINE; LIDOCAINE; METHOTREXATE; MINOCYCLINE; OMEPRAZOLE; PREDNISONE; ROFECOXIB; TRICYCLIC ANTIDEPRESSANT AGENT;

ACTION POTENTIAL; ADULT; AGED; ARTICLE; CARPAL TUNNEL SYNDROME; CLINICAL ARTICLE; DRUG HYPERSENSITIVITY; DYSESTHESIA; ELECTROPHYSIOLOGY; FEMALE; HUMAN; MALE; MUSCLE WEAKNESS; NERVE COMPRESSION; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; PARESTHESIA; PERIPHERAL NEUROPATHY; QUANTITATIVE DIAGNOSIS; SCLERODERMA; SENSITIVITY AND SPECIFICITY; SENSORY ANALYSIS; SIDE EFFECT; SKIN NERVE; SYMPTOMATOLOGY; TENDON REFLEX; VIBRATION SENSE;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; NERVE FIBERS; NEURAL CONDUCTION; PERIPHERAL NERVES; PERIPHERAL NERVOUS SYSTEM DISEASES; REFLEX, STRETCH; SCLERODERMA, SYSTEMIC; SOMATOSENSORY DISORDERS; WALLERIAN DEGENERATION;

EID: 0041430553     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.10439     Document Type: Article

References (22)

1. Averbuch-Heller L, Steiner I, Abramsky O. Neurologic manifestations of progressive systemic sclerosis. Arch Neurol 1992;49:1292-1295.
2. Brick JE, Brick JF. Neurologic manifestations of rheumatologic disease. Neurol Clin 1989;7:629-639.
3. Dyck P, Litchy W, Lehman K, Hokanson J, Low P, O'Brien P. Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology 1995;45:1115-1121.
4. Forster C, Brandt T, Hund E, Meinck HM, von Kummer R, Breitbart A, Wildemann B. Trigeminal sensory neuropathy in connective tissue disease: evidence for the site of the lesion. Neurology 1996;46:270-271.
5. Gordon R, Silverstein A. Neurologic manifestations in progressive systemic sclerosis. Arch Neurol 1970;22:126-134.
6. Hellmann D, Laing T, Petri M, Whiting-O'Keefe Q, Parry G. Mononeuritis multiplex: the yield of evaluations for occult rheumatologic diseases. Medicine 1988;67:145-153.
7. Jimenez-Moreno J, Selva-O'Callaghan A, Rovira-Canellas A, Solans-Laque R, Len O, Olias M, Fonollosa-Pla V, Vilardell-Tarres M. Trigeminal sensory neuropathy in systemic sclerosis. Br J Rheumatol 1997;37:587-589.
8. Lee P, Bruni J, Sukenik S. Neurological manifestations in systemic sclerosis (scleroderma). J Rheumatol 1984;11:480-483.
9. Leinwand I, Duryee W, Richter MN. Scheroderma (based on a study of over 150 cases). Ann Intern Med 1954;41:1003-1141.
10. LeRoy E, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TJ, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-205.
11. Machet L, Vaillant L, Machet MC, Esteve E, Muller C, Khallouf R, Lorette G. Carpal tunnel syndrome and systemic sclerosis. Dermatology 1992;185:101-103.
12. Medsger T. Systemic sclerosis (scleroderma): clinical aspects. In: Koopman W, editor. Arthritis and allied conditions, 14th ed. Philadelphia: Lippincott Williams & Wilkins, 2001. p 1590-1624.
13. O'Brien P, Dyck P. Procedures for setting normal values. Neurology 1995;45:17-23.
14. Oddis C, Eisenbeis C, Reidbord H, Steen V, Medsger T. Vasculitis in systemic sclerosis: association with Sjogren's syndrome and the CREST variant. J Rheumatol 1987;14:942-948.
15. Peterson L, Nelson A, Su W, Mason T, O'Fallon W, Gabriel S. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993. J Rheumatol 1997;24:73-80.
16. Richter R. Peripheral neuropathy and connective disease. J Neuropathol Exp Neurol 1954;13:168-180.
17. Sant S, Murphy G. Neurotrophic ulceration in systemic sclerosis. Clin Exp Dermatol 1994;19:65-66.
18. Schady W, Sheard A, Hassell A, Holt L, Jayson MIV, Klimiuk P. Peripheral nerve dysfunction in scleroderma. Q J Med 1991;80:661-675.
19. Seibold J, Furst D, Clements P. Treatment of systemic sclerosis by disease modifying agents. In: Clements P, Furst D, editors. Systemic sclerosis. Baltimore: Williams & Wilkins, 1996. p 535-548.
20. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic Sclerosis (scleroderma). Arthritis Rheum 1980;23:581-590.
21. Tuffanelli D, Winkelmann R. Systemic scleroderma. A clinical study of 727 cases. Arch Dermatol 1961;84:359-371.
22. Vicente A, Herrero C, Martin E, Valls J, Graus F, Mascaro JM, Trigeminal sensory neuropathy in systemic sclerosis. Clin Exp Dermatol 1991;16:403.